Model
Edge
CTI BioPharma Corp
0000891293
Filing type
8-K
Filing date
Jun 25, 2023
Updated
Jun 26, 2023 ยท 2:51 AM
Copy reference
Filing
8-K
End of Material Contract, Completing Asset Acquisition or Sale, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Chan
Exhibits
EX-3.1
EX-3.1
EX-3.2
EX-3.2